A Japanese logistics company is planning to integrate a blockchain network into a new transport system that will be developed next year.
According to an article from the Nikkei newspaper, Nippon Express plans to invest up to 100 billion yen – about one billion USD – in a blockchain-based drug transport network. The Tokyo-based company plans to develop its own line of medicines from 2021, which requires real-time tracking of products through warehouses and status updates for quality control teams.
Nippon Express will collaborate with others at home and abroad to develop this pharmaceutical network that is compatible with blockchain. Accenture will build a system of sensors to monitor the temperature of products on trucks and in warehouses. In addition, Intel Japan will provide RFID (radio frequency identification) tags to track the location of each shipment.
Combined, these sensors and RFID tags enable manufacturers, wholesalers and medical institutions to follow the pharmaceutical development process in real time using blockchain.
From importing raw materials and products to delivery to medical institutions, the contributions from Intel and Accenture are installed in Nippon Express factories, warehouses and trucks. Data in each phase is uploaded to the blockchain, with the state, position and status of each shipment.